Umlaut.bio
Umlaut.bio is a developer of tRNA-modifying small molecules founded in 2024 by Bastian Linder.
Country
Email Address
info@umlaut.bio
Founded Date
2024
Headquarters
Industry
Investors
Latest Funding Round Date
February 20, 2026
Latest Funding Round Amount (USD)
3,500,000
Latest Funding Type
LinkedIn URL
Number of Employees (Ranges)
1 – 10
Total Funding Amount (USD)
3,500,000
Official Website
Find more companies like Umlaut.bio
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.